Review



bsmbiigested lenticrisprv2 backbone  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Addgene inc bsmbiigested lenticrisprv2 backbone
    Bsmbiigested Lenticrisprv2 Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 487 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsmbiigested lenticrisprv2 backbone/product/Addgene inc
    Average 98 stars, based on 487 article reviews
    bsmbiigested lenticrisprv2 backbone - by Bioz Stars, 2026-05
    98/100 stars

    Images



    Similar Products

    98
    Addgene inc bsmbiigested lenticrisprv2 backbone
    Bsmbiigested Lenticrisprv2 Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsmbiigested lenticrisprv2 backbone/product/Addgene inc
    Average 98 stars, based on 1 article reviews
    bsmbiigested lenticrisprv2 backbone - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    96
    Addgene inc plenticrisprv2 backbones carrying neomycin
    Plenticrisprv2 Backbones Carrying Neomycin, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plenticrisprv2 backbones carrying neomycin/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    plenticrisprv2 backbones carrying neomycin - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc lenticrisprv2 blasticidin backbone
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Lenticrisprv2 Blasticidin Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lenticrisprv2 blasticidin backbone/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    lenticrisprv2 blasticidin backbone - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc lenticrisprv2 backbone plasmid
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Lenticrisprv2 Backbone Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lenticrisprv2 backbone plasmid/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    lenticrisprv2 backbone plasmid - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc lenticrisprv2 backbone
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Lenticrisprv2 Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lenticrisprv2 backbone/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    lenticrisprv2 backbone - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    95
    Addgene inc backbone vector lenticrisprv2 mcherry
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Backbone Vector Lenticrisprv2 Mcherry, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/backbone vector lenticrisprv2 mcherry/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    backbone vector lenticrisprv2 mcherry - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Addgene inc lenticrispr v2 mcherry backbone
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Lenticrispr V2 Mcherry Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lenticrispr v2 mcherry backbone/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    lenticrispr v2 mcherry backbone - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    96
    Addgene inc lentiviral backbone lenticrisprv2
    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned <t>to</t> <t>lentiCRISPRv2-blasticidin</t> vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).
    Lentiviral Backbone Lenticrisprv2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentiviral backbone lenticrisprv2/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    lentiviral backbone lenticrisprv2 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned to lentiCRISPRv2-blasticidin vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).

    Journal: bioRxiv

    Article Title: MYC-ATF4-ASS1 axis governs intracellular arginine synthesis and dictates the immune microenvironment in melanoma

    doi: 10.64898/2026.02.27.707779

    Figure Lengend Snippet: MYC regulates ASS1 expression in the context of BRAF/MEK inhibition . ( a and b ) Melanoma cells were treated with Dabrafenib/Trametinib (D/T) for 5 days. Total mRNAs were isolated and subjected to qPCR to detect the mRNA expression of ASS1 and MYC ( a ). The same treatment was performed, protein lysates were collected, and ASS1 and MYC protein expression were detected by western blot ( b ). β-ACTIN was used as a loading control. ( c-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting MYC (sgMYC) were designed, cloned to lentiCRISPRv2-blasticidin vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, total mRNAs from survived cells were isolated and subjected to qPCR to quantify mRNA expression of ASS1 ( c ), while protein lysates were collected and used for western blot to detect protein expression of ASS1 and MYC ( d ). sgAss1 was used as a positive control. β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).

    Article Snippet: Briefly, non-targeting or gene-specific targeting oligos were annealed and ligated into a lentiCRISPRv2-blasticidin backbone (Addgene, 98293) cut with BsmBI-v2 (NEB, R0739S).

    Techniques: Expressing, Inhibition, Isolation, Western Blot, Control, Clone Assay, Plasmid Preparation, Selection, Positive Control, Staining

    ATF4 correlates with and regulates ASS1 expression . ( a ) WM4380-2 cells were treated with DMSO, D/T, ADI or D/T+ADI as shown in . Total mRNA were isolated and subjected to bulk RNA-seq. Normalized reads of ATF4 were presented. ( b ) Correlative analysis of ATF4 and ASS1 was performed using our bulk RNA-seq data as indicated in . R and P value were shown. ( c ) Correlative analysis of ATF4 and ASS1 was performed exploiting public dataset of spatical single cell RNA-seq. R and P valude were provided. ( d-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting ATF4 (sgATF4) were designed, cloned to lentiCRISPRv2-blasticidin vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, protein lysates were collected and used for western blot to detect protein expression of ASS1 and ATF4 ( d ). β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).

    Journal: bioRxiv

    Article Title: MYC-ATF4-ASS1 axis governs intracellular arginine synthesis and dictates the immune microenvironment in melanoma

    doi: 10.64898/2026.02.27.707779

    Figure Lengend Snippet: ATF4 correlates with and regulates ASS1 expression . ( a ) WM4380-2 cells were treated with DMSO, D/T, ADI or D/T+ADI as shown in . Total mRNA were isolated and subjected to bulk RNA-seq. Normalized reads of ATF4 were presented. ( b ) Correlative analysis of ATF4 and ASS1 was performed using our bulk RNA-seq data as indicated in . R and P value were shown. ( c ) Correlative analysis of ATF4 and ASS1 was performed exploiting public dataset of spatical single cell RNA-seq. R and P valude were provided. ( d-f ) Non-targeting sgRNA (sgNT) or sgRNAs targeting ATF4 (sgATF4) were designed, cloned to lentiCRISPRv2-blasticidin vector, used to package lentivirus, and infect target melanoma cells. After blasticidin selection, protein lysates were collected and used for western blot to detect protein expression of ASS1 and ATF4 ( d ). β-ACTIN was used as a loading control. Meanwhile, blasticidin resistant cells were seeded onto 6-well plates, treated with PBS or ADI-PEG20 for 10 days, and crystal violet was used to stain colonies formed. Representative images were shown ( e ) and area percentage of stained colonies were quantified ( f ).

    Article Snippet: Briefly, non-targeting or gene-specific targeting oligos were annealed and ligated into a lentiCRISPRv2-blasticidin backbone (Addgene, 98293) cut with BsmBI-v2 (NEB, R0739S).

    Techniques: Expressing, Isolation, RNA Sequencing, Single Cell, Clone Assay, Plasmid Preparation, Selection, Western Blot, Control, Staining